Global Wealth Management Investment Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Global Wealth Management Investment Advisory's BMY Position: Q1 2024 in Review
Global Wealth Management Investment Advisory sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 385 shares — an estimated $19.8K sold.
Global Wealth Management Investment Advisory first reported a position in BMY in Q4 2018 and held it in 18 quarters. The position peaked at $245K in Q4 2018. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- Global Wealth Management Investment Advisory reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
- Global Wealth Management Investment Advisory sold 385 Bristol-Myers Squibb shares in Q1 2024, an estimated $19.8K.
- Global Wealth Management Investment Advisory first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 18 quarters.
- Global Wealth Management Investment Advisory's Bristol-Myers Squibb position peaked at $245K in Q4 2018.
- 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on Global Wealth Management Investment Advisory's 13F filing for Q1 2024, filed 10 May 2024.